FDA Inspection 695691 — Fresenius Kabi AB

Fresenius Kabi AB — FEI 3002631703

The FDA completed an inspection of Fresenius Kabi AB on September 30, 2010 in Uppsala. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 30, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Uppsala (Sweden)

Citations

IDCFRDescription
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
122721 CFR 211.67(c)Cleaning/maintenance records not kept
135821 CFR 211.100(b)SOPs not followed / documented
357021 CFR 211.100(a)Approval and review of procedures
357221 CFR 211.100(b)Procedure Deviations Recorded and Justified